Why the study?
The study was conducted to compare the Hestia rule versus the simplified Pulmonary Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism for home treatment.
Does triaging with the Hestia rule compared to sPESI maintain safety and effectiveness for home treatment in normotensive patients with acute pulmonary embolism?
Does triaging with the Hestia rule compared to sPESI maintain safety and effectiveness for home treatment in normotensive patients with acute pulmonary embolism?
The Hestia rule and sPESI are equally safe and effective for triaging normotensive acute PE patients for home treatment, allowing over a third of patients to be managed at home safely.
Answers are grounded in this paper and cite their sources.
Supports home treatment selection with either rule in normotensive PE; confirms comparable safety and effectiveness in RCT.
AIMS: The aim of this study is to compare the Hestia rule vs. the simplified Pulmonary Embolism Severity Index (sPESI) for triaging patients with acute pulmonary embolism (PE) for home treatment. METHODS AND RESULTS: Normotensive patients with PE of 26 hospitals from France, Belgium, the Netherlands, and Switzerland were randomized to either triaging with Hestia or sPESI. They were designated for home treatment if the triaging tool was negative and if the physician-in-charge, taking into account the patient's opinion, did not consider that hospitalization was required. The main outcomes were the 30-day composite of recurrent venous thrombo-embolism, major bleeding or all-cause death (non-inferiority analysis with 2.5% absolute risk difference as margin), and the rate of patients discharged home within 24 h after randomization (NCT02811237). From January 2017 through July 2019, 1975 patients were included. In the per-protocol population, the primary outcome occurred in 3.82% (34/891) in the Hestia arm and 3.57% (32/896) in the sPESI arm (P = 0.004 for non-inferiority). In the intention-to-treat population, 38.4% of the Hestia patients (378/984) were treated at home vs. 36.6% (361/986) of the sPESI patients (P = 0.41 for superiority), with a 30-day composite outcome rate of 1.33% (5/375) and 1.11% (4/359), respectively. No recurrent or fatal PE occurred in either home treatment arm. CONCLUSIONS: For triaging PE patients, the strategy based on the Hestia rule and the strategy based on sPESI had similar safety and effectiveness. With either tool complemented by the overruling of the physician-in-charge, more than a third of patients were treated at home with a low incidence of complications.
No takes yet. Share an insight, caveat, or question.
Roy et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: